Recently, Oh and coworkers [38] have attempted to integrate data on estrogen responsiveness in MCF-7 cells in vitro with gene expression and clinical outcome data from 65 ER-positive and/or PgR-positive breast cancer patients to predict outcome for hormone responsive breast cancer. Here, ESR1 is linked to breast cancer.